Global Bulk Drug Raw Materials Category - Procurement Market Intelligence Report

This procurement report offers key insights on the best practices for supplier selection and the strategies for category management.

  • Published: Nov 2017
  • Pages: 97
  • SKU: IRCMSTR14650
See more Pharma and Healthcare reports

Want to know more about this procurement report?

You can get a FREE sample of any report on our site.

What’s in a sample report?
  • $ 2500
  • $ 1500

Choose your licensing options

Single User + 0
Five User + $ 250
Enterprise + $ 500
Global + $ 3500

Key Features of Report


Supply Market Insights
Procurement Best Practices
Cost Saving Opportunities
Pricing Models
Negotiation Strategies
Category Risk Analysis
Key Supplier Analysis
Supplier Capability Matrix


Bulk Drug Raw Materials - Category Spend Analysis


According to analysts at SpendEdge, one of the key growth drivers for the bulk drug raw materials market is the technological advances in manufacturing processes. The pharmaceutical raw material industry registers strong technological advances over the past few years. Technologies such as nanotechnology help suppliers in improving the efficacy and customization aspect of drug materials. In addition, the increasing investment of suppliers in R&D aids to the technological advancement. Suppliers inculcate advanced technologies such as automation in lyophilization, modular continuous flow processing system, adoption of sensors for process control, and semi-automatic powder handling technology in the entire process of raw material manufacturing. These improvements of technologies support suppliers to enhance their productivity and quality of raw materials produced. The technologies mentioned above aid suppliers to achieve consistent cost savings through factors such as low-impurity rate and automation of the entire process, which also reduces lead time. This leads to rise in profitability for suppliers, which will help buyers grow and expand in untapped regions through expansion and add new business segment.

One of the market trends is the paradigm shift from batch production to continuous production. The pharmaceutical raw material industry, especially the biopharma segment, is heading toward continuous production from its traditional batch production. The shift is mainly because of the FDA's mandate on raw material manufacturers to switch to continuous production and the productivity is estimated to increase nearly by 30%. Manufacturers can achieve significant growth in productivity of continuous output compared with batch production due to the rationale below:

  • It helps in cost-savings by reducing inventory and transportation costs of raw materials
  • Enhances productivity – more units completed in less time compared with batch production
  • Reduces overhead costs by increasing stability and reducing lead times due to the availability of materials throughout the year

For instance, Novartis employs continuous production to manufacture antimalarial raw material to meet the global demand for antimalarial drugs.

Bulk Drug Raw Materials - Procurement Best Practices


One of the procurement best practices for buyers is to integrate Big Data analytics into the procurement process. Buyers should adopt Big Data analytics in sourcing processes to achieve the following benefits:

  • Valuable insights such as pricing trends from the historic data
  • Demand projection of the bulk drug raw materials during the contract tenure
  • Inventory management through analysis of required inventories, holding time, and time to purchase
  • Analysis of the toxicity and impurity of drug materials
  • Adoption of blockchain technology using Big Data can also improve the security of the patented drug and restrict API counterfeiting

Also, Big Data analytics will eradicate the challenge of transparency in the supply chain through real-time visibility of the data by either party.

Bulk Drug Raw Materials  - Procurement Challenges


According to this procurement research, one of the key procurement challenges faced by buyers is the quality issues in materials procured from emerging countries. Emerging countries such as China, India, Brazil, and Israel constitute major share of production for bulk drug raw materials. The global bulk drug raw material market lacks regulations in terms of the production of suppliers and major production of raw materials comes from local players. As a result, the increase in local players and incompetence of regional regulatory standards, which is yet not equipped to control the quality standards, lead to counterfeiting and production of materials that lack industry standards.

Bulk drug raw materials refer to the substances that are used to manufacture active pharmaceutical ingredients. These ingredients provide therapeutic effects in a drug. This upcoming procurement research, which is part of SpendEdge’s pharma and healthcare category, would provide actionable insights on the pricing strategies, market trends, procurement best practices, and the supply landscape for the global bulk drug raw materials market.

Category overview of the global bulk drug raw materials market

Based on the application, analysts at SpendEdge categorize bulk drug raw materials into:

  • Biologics
  • Small molecules

Additionally, this report also considers segmentation of the market based on geographies including North America, South America, APAC, Europe, and MEA.

This upcoming procurement research report on the global bulk drug raw materials market would provide detailed analysis into the continuously evolving supplier landscape to help improve source-to-contract cycle performance. Moreover, it would help sourcing professionals develop enhanced category strategies, boost savings, understand supplier and market challenges, and implement sourcing best practices.

This report can be personalized according to your needs. Contact us now!



  • TAKEAWAY 01 | Market Overview
  • TAKEAWAY 02 | Demand and Supply Snapshot
  • TAKEAWAY 03 | Key Market Dynamics
  • TAKEAWAY 04 | Supply Market Highlights
  • TAKEAWAY 05 | Pricing Insights
  • TAKEAWAY 06 | Procurement Insights


  • Category Definition
  • Research Methodology


  • Category Spend Analysis
  • Category Maturity by Regions
  • Demand-Supply Shifts
  • Regional Demand-Supply Snapshot
  • Market Developments
  • Regional Impact of Trends
  • Key Category Growth Drivers and Corresponding Regional Impacts
  • Major Category Growth Constraints and Corresponding Regional Impacts
  • Key Current Technological Innovations
  • Major Regulatory Frameworks
  • Strategic Sustainability Practices
  • Porter’s Five Forces
  • PESTLE Analysis


  • Supplier Operational Capability Matrix
  • Other Prominent Suppliers by Region: Operational Capability Matrix
  • Supplier Functional Capability Matrix
  • Other Prominent Suppliers by Region: Functional Capability Matrix
  • Key Clients/Partners
  • Supplier Cost Breakup
  • Supplier Positioning Matrix


  • Pricing Models Snapshot
  • Pricing Models – Pros and Cons
  • Indicative Pricing


  • Major Category Requirements
  • Major Procurement Pain Points
  • Category Sourcing Evolution Matrix
  • Procurement Best Practices
  • Cost-saving Opportunities
  • Supplier Selection Criteria
  • Category Negotiation Strategies
  • SLA Terms
  • Supplier Evaluation Criteria
  • Category Risk Analysis


  • Merck
  • Teva
  • Pfizer
  • AstraZeneca
  • BASF     


  • Glossary
  • Key Notes
  • About Us

Research Framework

SpendEdge presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key category influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.


Primary research

  • Procurement heads
  • Category managers
  • Sourcing consortium professionals
  • Industry experts and thought leaders
  • Procurement managers
  • Category heads of suppliers
  • Client account heads/managers
  • Client and industry consultants

Secondary research

  • Industry journals and reports
  • Periodicals and new articles
  • Category webinars
  • Internal categiry playbooks
  • Industry and government websites on regulations and compliance
  • Internal databases
  • Industry blogs/thought leader briefings



Do you purchase multiple reports in a year? Explore our excititng subscription packages.